Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-25-250744
Filing Date
2025-10-27
Accepted
2025-10-27 07:56:26
Documents
123
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 6-K d69958d6k.htm   iXBRL 6-K 479573
2 EX-99.1 d69958dex991.htm   iXBRL EX-99.1 2377877
3 EX-99.2 d69958dex992.htm EX-99.2 624011
4 EX-99.3 d69958dex993.htm EX-99.3 775856
6 GRAPHIC g69958dsp6a.jpg GRAPHIC 935
7 GRAPHIC g69958dsp6b.jpg GRAPHIC 935
8 GRAPHIC g69958dsp6c.jpg GRAPHIC 948
  Complete submission text file 0001193125-25-250744.txt   17246706

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA sny-20250630.xsd EX-101.SCH 2404462
125 EXTRACTED XBRL INSTANCE DOCUMENT d69958d6k_htm.xml XML 4064495
Mailing Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017
Business Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

EIN.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31368 | Film No.: 251417510
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)